Dr Yassar Alamri
MBChB
This person is no longer at the institute and this page is for historical access to their publications only
Publications
Provided on request for non-commercial personal use by researchers.
2020
(2020). Exploring eye movements of Parkinson’s disease patients performing the Judgement of Line Orientation test. Journal of Clinical Neuroscience, 76, 183-188. 10.1016/j.jocn.2020.04.031
(2020). Variations in the patterns of prevalence and therapy in Australasian Parkinson’s disease patients of different ethnicities. BMJ Neurology Open, 2(1), e000033.. 10.1136/bmjno-2019-000033
2018
(2018). Supplementation of blackcurrant anthocyanins increased cyclic glycine-proline in the cerebrospinal fluid of Parkinson patients: potential treatment to improve insulin-like growth factor-1 function. Nutrients, 10, 714. 10.3390/nu10060714
(2018). The Symbol-Digit Modalities Test in mild cognitive impairment: evidence from Parkinson's disease patients. European Neurology, 79, 206-210. 10.1159/000485669
2017
(2017). Qualitative analysis of Parkinson’s disease information on social media: the case of YouTube™. EPMA Journal, 8, 273-277.
(2017). Errors on the MoCA's animal-naming: findings from Parkinson’s disease patients. International Psychogeriatrics, 1-2. 10.1017/S1041610217000345
2016
(2016). Repeated lumbar punctures for non-clinical indications: how do patients feel? European Neurology, 76(3-4), 123-124. 10.1159/000449056
(2016). Plasma exosome concentration may correlate with cognitive impairment in Parkinson’s disease. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 4, 107-108. 10.1016/j.dadm.2016.08.002
2015
(2015). Anxiety and depression in Parkinson’s disease patients in Saudi Arabia Global neurology. Journal of the Neurological Sciences, 358, 457-458. 10.1016/j.jns.2015.07.051
(2015). Parkinson’s disease in the Gulf Countries: An updated review. European Neurology, 74(3-4), 222-225. 10.1159/000442283
(2015). Mental health and Parkinson's disease: from the cradle to the grave. British Journal of General Practice, 65(634), 258-9. 10.3399/bjgp15X684985
2014
(2014). C-type natriuretic peptide in Parkinson's disease: reduced secretion and response to deprenyl. Journal of Neural Transmission, 121(4), 371-378. 10.1007/s00702-013-1123-9
Abstracts and Short papers
2019
(2019). Sensorimotor integration assessment by the Symbol-Digit modalities test in patients with Parkinson’s disease. Neurosciences 24, 143. 10.17712/nsj.2019.2.20190002
2013
(2013). Animal-naming in Parkinson's disease (Abstract). 2013 Neuroscience Meeting Planner San Diago, CA: Society for, 431, Program No.10/N5..
(2013). Tea with milk and sugar: gaze and action coordination in a real-world task in Parkinsons disease (Abstract). Proceedings of the 17th European Conference on Eye Movement Research, Lund, Journal of Eye Movement Research, 6(3), 512.